BRIEF-FTC approves final order settling charges for Abbott's deal with St. Jude Medical
February 23, 2017 at 13:18 PM EST
* Approved final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would likely be anticompetitive
